Neuroimaging in Monitoring the Therapy and Recurrence of Brain Tumors

Rock JP Scarpace L Hearshen D : Associations among magnetic rsonance spectroscopy, apparent diffusion coeffocients and image guided histopathology with special attention to radiation necrosis, Neurosurgery 54: 1111–1119, 2004.

Macdonald DR Cascino TL Schold SC : Response criteria for phase II studies of supratentorial malignant glioma. Journal of Clinical Oncology 8: 1277–1280, 1990.

Henson JW Ulmer S Harris GJ : Brain tumor imaging in clinical trials, American Journal of Neuroradiology, 29: 419–424, 2008.

Galanis E Buckner JC Maurer MJ : Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods, Neuro-Oncology 8: 156–165, 2006.

Mandonnet E Jbabdi S Taillandier L : Preoperative estimation of residual volume for WHO grade II glioma resected with intraoperative functional mapping. Neuro Oncol 9: 63–69, 2007.

Dempsey MF Condon BR Hadley DM : Measurement of Tumor “Size” in Recurrent Malignant Glioma: 1D, 2D, or 3D? American Journal of Neuroradiology 26: 770–776, 2005.

Lamborn KR Yung WKA Chang SM : Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas, Neuro-oncology, April 2008: 162–170.

Heesters MA Wijrdeman HK Struikmans H : Brain tumor delineation based on CT and MR imaging. Implications for radiotherapy treatment planning. Strahlenther Onkol 169: 729–33, 1993.

Brandes AA Rigon A Monfardini S : Radiotherapy of the brain in elderly patients. Contra. Eur J Cancer 36: 447–452, 2000.

Brandes AA Tosoni A Spagnolli F : Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology. Neuro Oncol Advance 9: 2–7; 2008.

Brandsma D Staplers L Taal W : Clinical features, mechanisms and management of pseudoprogression in malignant gliomas. Lancet Oncol, 9: 453–61. 2008.

Kumar AJ Leeds NE Fuller GN : Malignant Gliomas: MR Imaging Spectrum of Radiation Therapy-and Chemotherapy-induced Necrosis of the Brain after Treatment, Radiology 217: 377–384, 2000.

Stupp R Roila F : Clinical recommendations: Malignant glioma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up Annals of Oncology 19: 83–85, 2008.

Rabinov JD Lee PL Barker FG : In Vivo 3-T MR Spectroscopy in the Distinction of Recurrent Glioma versus Radiation Effects: Initial Experience Radiology 225: 871–879, 2002.

Traber F Block W Flacke S : ¹H-MR Spectroscopy of brain tumors in the course of radiation therapy: use of fast spectroscopic imaging and single-voxel spectroscopy for diagnosing recurrence. Rofo 174: 33–42, 2002.

Weybright P Sundgren PC Maly P : Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy. AJR Am J Roentgenol 185: 1471–1476, 2005.

Schlemmer HP Bachert P Herfarth KK : Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy. Am J Neuroradiol 22: 1316–1324, 2001.

Zeng Q-S Li Ch. F Liu H : Distinction between recurrent glioma and radiation injury using magneticresonance spectroscopy in combination with diffusion-weighted imaging, Int. J. Radiation Oncology Biol. Phys 68: 151–158, 2007.

Ando K Ishikura R Nagami Y : Usefulness of Cho/Cr ratio in proton MR spectroscopy for differentiating residual/recurrent glioma from non-neoplastic lesions Nippon Igaku Hoshasen Gakkai Zasshi 64: 121–26, 2004.

Lichy MP Henze M Plathow C : Metabolic imaging to follow stereotactic radiation of gliomas - the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT. Rofo 176: 1114–21, 2004.

Rock JP Hearshen D Scarpace L : Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis. Neurosurgery 51: 912–919, 2002.

Graves EE Nelson SJ Vigneron DB : Serial Proton MR Spectroscopic Imaging of Recurrent Malignant Gliomas after Gamma Knife Radiosurgery. American Journal of Neuroradiology 22: 613–624, 2008.

Sundgren PC Fan X Weybright P : Differentiation of recurrent brain tumor versus radiation injury using diffusion tensor imaging in patients with new contrast-enhancing lesions. Magnetic Resonance Imaging 24: 1131–1142, 2006.

Chenevert T McKeever P Ross B : Monitoring early response of experimental brain tumors to therapy using diffusion magneticresonance imaging. Clin Cancer Res 3: 1457–66, 1997.

Chenevert T Stegman L Taylor JM : Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 92: 2029–36, 2000.

Mardor Y Pfeffer R Spiegelmann R : Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. J Clin Oncol 21: 1094–100, 2003.

Dzik-Jurasz A Domenig C George M : Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 360: 307–8, 2002.

Provenzale JM Mukundan S Barboriak DP : Diffusion-weighted and Perfusion MR Imaging for Brain Tumor Characterization and Assessment of Treatment Response Radiology 239: 632–649, 2006.

Di Chiro G Oldfield E Wright DC : Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. Am J Roentgenol 150: 189–197, 1988.

Haymaker W Ibrahim MZ Miquel J : Delayed radiation effects in the brains of monkeys exposed to X-and g-rays. J Neuropathol Exp Neuro 27: 50–7, 1968.

Sugahara T Korog Y Tomiguchi S : Posttherapeutic Intraaxial Brain Tumor: The Value of Perfusion-sensitive Contrast-enhanced MR Imaging for Differentiating Tumor Recurrence from Nonneoplastic Contrast-enhancing Tissue, American Journal of Neuroradiology 21: 901–909, 2000.

Sugahara T Korogi Y Kochi M : Relationship of MR determined cerebral blood volume maps to histologic and angiographic vascularities of gliomas. Am J Roentgenol 171: 1479–1485, 1998.

Cao Y Tsien CI Nagesh V : Survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT Int J Radiat Oncol Biol Phys. 64: 876–885, 2006.

Provenzale JM : Imaging of angiogenesis: Clinical Techniques and novel imaging methods, Am J Roentgenol 188: 11–23, 2007.

Chen W : Clinical applications of PET in brain tumors. J Nucl Med 48: 1468–1481; 2007.

Popperl G Gotz C Rachinger W : Value of O-(2-[18F]fluoroethyl)-L-tyrosine PET for the diagnosis of recurrent glioma. Eur J Nucl Med Mol Imaging 31: 1464–1470, 2004.